2004
DOI: 10.1074/jbc.m314116200
|View full text |Cite
|
Sign up to set email alerts
|

Casein Kinase 1 Delta Phosphorylates Tau and Disrupts Its Binding to Microtubules

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
117
0

Year Published

2005
2005
2017
2017

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 136 publications
(117 citation statements)
references
References 75 publications
(72 reference statements)
0
117
0
Order By: Relevance
“…As illustrated in Figure 4c, after 6-8 h of incubation with IC261 (see also Materials and methods; Cooper and Lampe (2002) and Li et al (2004)), the signal intensity of nm23 phosphorylation decreased by 65% (quantified by imaging scan analyses; data not shown). To confirm any effects of inhibition of CKI on nm23 phosphorylation in cells and to avoid any misinterpretation relating to the relatively high levels of IC261 used (see below), here we also treated the MDA-MB-H1-177 cells with the two additional CKI inhibitors indicated above: D4476 and CKI-7 (Figure 4d).…”
Section: Resultsmentioning
confidence: 92%
See 1 more Smart Citation
“…As illustrated in Figure 4c, after 6-8 h of incubation with IC261 (see also Materials and methods; Cooper and Lampe (2002) and Li et al (2004)), the signal intensity of nm23 phosphorylation decreased by 65% (quantified by imaging scan analyses; data not shown). To confirm any effects of inhibition of CKI on nm23 phosphorylation in cells and to avoid any misinterpretation relating to the relatively high levels of IC261 used (see below), here we also treated the MDA-MB-H1-177 cells with the two additional CKI inhibitors indicated above: D4476 and CKI-7 (Figure 4d).…”
Section: Resultsmentioning
confidence: 92%
“…In these assays, IC261 was used at a concentration of 50 mM, CKI-7 at 400 mM, and D4476 at 25 mM, according to the concentrations reported in the literature (Cooper and Lampe, 2002;Izeradjene et al, 2004;Li et al, 2004;Rena et al, 2004).…”
Section: Resultsmentioning
confidence: 99%
“…In vitro, GSK-3 phosphorylates tau on ~40 Ser/Thr residues, and 348 CK1 is the only other kinase comparable to GSK-3 in that it phosphorylates tau residues in similar numbers [31] . GSK-3 phosphorylation reduces the capability of tau to promote microtubule assembly in vitro and in cells [33,34] . GSK-3 together with the activity of other kinases such as CK1, Cdk5, and MARK, has the ability to signifi cantly affect tau phosphorylation and modulate its neuronal function [35][36][37][38] .…”
Section: Phosphorylation Of Tau Is Mainly Regulated Through Kinases Amentioning
confidence: 99%
“…As a result, they can function processively or synergize with other protein kinases to support high-stoichiometry substrate phosphorylation [14]. CK1 activity associates with brain microtubules [42] and contributes to basal levels of tau phosphorylation in cultured cells [28]. Moreover, at least one isoform, Ckiδ, can phosphorylate tau and modulate its binding affinity for microtubules when highly overexpressed in cultured cells [28].…”
mentioning
confidence: 99%
“…CK1 activity associates with brain microtubules [42] and contributes to basal levels of tau phosphorylation in cultured cells [28]. Moreover, at least one isoform, Ckiδ, can phosphorylate tau and modulate its binding affinity for microtubules when highly overexpressed in cultured cells [28]. To identify which isoforms gain access to substrates under pathophysiologically relevant conditions, their colocalization with intact AD lesions has been investigated immunohistochemically in diseased tissue.…”
mentioning
confidence: 99%